Understanding views of patients on biologics for psoriasis amid the COVID-19 pandemic.

Pandher, K; Porter, C L; Patel, H S; Huang, W W; Feldman, S R

Pandher, K; Porter, C L; Patel, H S; Huang, W W; Feldman, S R.

Pandher K; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Porter CL; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Patel HS; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Huang WW; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Feldman SR; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

J Eur Acad Dermatol Venereol ; 35(4): e249-e251, 2021 Apr.

Article in English | MEDLINE | ID: covidwho-979741

Subject(s)

Biological Products/therapeutic use; COVID-19/epidemiology; Health Knowledge, Attitudes, Practice; Psoriasis/drug therapy; COVID-19/diagnosis; COVID-19/therapy; Humans; Psoriasis/psychology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / Biological Products / Health Knowledge, Attitudes, Practice / COVID-19 Type of study: Diagnostic study / Observational study / Qualitative research Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2021 Document Type: Article Affiliation country: Jdv.17091

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google